(Q35240385)

7 August 2017

Chronic Treatment with the 5-HT1A Receptor Partial Agonist Tandospirone Increases Hippocampal Neurogenesis (English)

1 reference

7 August 2017

1 reference

Masayoshi Mori

1

1 reference

7 August 2017

Yusuke Murata

2

1 reference

7 August 2017

Asami Matsuo

3

1 reference

7 August 2017

Tomoyo Takemoto

4

1 reference

7 August 2017

Kazunori Mine

5

1 reference

7 August 2017

3 January 2014

1 reference

7 August 2017

Neurology and therapy

1 reference

7 August 2017

3

1 reference

7 August 2017

1

1 reference

7 August 2017

67-77

1 reference

https://scigraph.springernature.com/pub.10.1007/s40120-013-0015-0

7 August 2017

0 references

cites work

Augmentation treatments with second-generation antipsychotics to antidepressants in treatment-resistant depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

A benzodiazepine impairs the neurogenic and behavioural effects of fluoxetine in a rodent model of chronic stress.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Serotonin receptors involved in antidepressant effects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Activity-based anorexia is associated with reduced hippocampal cell proliferation in adolescent female rats.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

The therapeutic potential of 5-HT1A receptors: a patent review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Adult hippocampal neurogenesis buffers stress responses and depressive behaviour

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Neuroregeneration in neurodegenerative disorders

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Regulatory Focus and Anxiety: A Self-Regulatory Model of GAD-Depression Comorbidity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

5-HT1A receptor-regulated signal transduction pathways in brain

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Region- and phase-dependent effects of 5-HT(1A) and 5-HT(2C) receptor activation on adult neurogenesis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Withdrawing Benzodiazepines in Primary Care

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Limitations in efficacy of antidepressant monotherapy.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Tandospirone in the treatment of generalised anxiety disorder and mixed anxiety-depression : results of a comparatively high dosage trial

27 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

27 July 2018

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Lack of deleterious effects of buspirone on cognition in healthy male volunteers.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Medication augmentation after the failure of SSRIs for depression.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Doublecortin expression levels in adult brain reflect neurogenesis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Efficacy of doublecortin as a marker to analyse the absolute number and dendritic growth of newly generated neurons in the adult dentate gyrus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Neurogenesis in adult mammals: some progress and problems.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Stress, glucocorticoids and structural plasticity of the hippocampus.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on daytime sleepiness and psychomotor functions: a comparative double-blind study with diazepam.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

The effects of chronic antidepressant treatment in an animal model of anxiety

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

Review of pharmacological treatment in mood disorders and future directions for drug development.

27 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Neurogenesis in the adult human hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Neurogenesis and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Is there a role for 5-HT1A agonists in the treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Major depressive disorder treatment guidelines in America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

The pharmacokinetics and pharmacodynamics of tandospirone in rats exposed to conditioned fear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Unbiased stereological estimation of the number of neurons in the human hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40120-013-0015-0

Increase in neurogenesis and behavioural benefit after chronic fluoxetine treatment in Wistar rats

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381917

A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26000223

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26000223

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The clinical efficacy of a 5-HT1A agonist, SM-3997, in the treatment of bulimia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26000223

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40120-013-0015-0

1 reference

7 August 2017

1 reference

7 August 2017

1 reference